Orforglipron, an Oral GLP-1 Receptor Agonist, in Early Type 2 Diabetes. Reply. Rosenstock J, Cox D, Denning M. N Engl J Med 2025;393:2277-2279.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Rosenstock J, Cox D, Denning M. Orforglipron, an Oral GLP-1 Receptor Agonist, in Early Type 2 Diabetes. Reply. N Engl J Med 2025;393:2277-2279.
PMID: 41337728